Development of initial loading procedure for teicoplanin in critically ill patients with severe infections

Area of Science:

• Pharmacology
• Infectious Diseases
• Critical Care Medicine

Background:

• Methicillin-resistant Staphylococcus aureus (MRSA) is a common hospital-acquired infection, particularly prevalent in intensive care units (ICUs).
• Effective treatment of MRSA infections in critically ill patients is crucial for favorable outcomes.
• Teicoplanin is an effective antibiotic against MRSA, with a recommended target trough concentration of 15-30 µg/mL.

Purpose of the Study:

• To determine the optimal initial loading dose regimen for teicoplanin in critically ill patients.
• To ensure prompt achievement of the target teicoplanin trough concentration (15-30 µg/mL).
• To guide teicoplanin administration in the ICU setting for severe MRSA infections.

Main Methods:

• A retrospective study was conducted on patients receiving teicoplanin in the ICU.
• The study analyzed the correlation between teicoplanin loading doses and trough concentrations on day 3.
• A regression equation was derived to predict trough concentrations based on loading doses.

Main Results:

• The mean loading dose was 11.5±1.0 mg/kg, resulting in a mean trough concentration of 18.9±5.9 µg/mL.
• A significant correlation (r=0.45, p=0.046) was found between loading dose and trough concentration.
• Simulated trough concentrations for 11.0 and 15.0 mg/kg loading doses were 17.5 and 27.8 µg/mL, respectively.

Conclusions:

• An initial loading dose of 11-15 mg/kg every 12 hours for 3 doses is recommended for teicoplanin.
• This regimen is suggested to promptly achieve the target trough concentration of 15-30 µg/mL by day 3.
• This finding supports optimized teicoplanin therapy for MRSA infections in ICU patients.